XML 25 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating Revenues:      
Total revenues $ 253,699 $ 268,403 $ 274,116
Operating Expenses:      
Compensation and benefits 74,675 80,761 74,515
Fund management and administration 60,515 61,502 56,686
Marketing and advertising 11,128 12,163 13,884
Sales and business development 10,579 18,276 17,153
Contractual gold payments (Note 12) 16,811 13,226 8,512
Professional and consulting fees 4,902 5,641 7,984
Occupancy, communications and equipment 6,427 6,302 6,203
Depreciation and amortization 1,021 1,045 1,301
Third-party distribution fees 5,219 6,968 6,611
Acquisition and disposition-related costs 416 902 11,454
Other 6,924 8,083 8,534
Total operating expenses 198,617 214,869 212,837
Operating income 55,082 53,534 61,279
Other Income/(Expenses):      
Interest expense (9,668) (11,240) (7,962)
(Loss)/gain on revaluation of deferred consideration – gold payments (Note 12) (56,821) (11,293) 12,220
Interest income 744 3,332 3,093
Impairments (Note 27) (22,752) (30,710) (17,386)
Loss on extinguishment of debt (Note13) (2,387)    
Other gains and losses, net 580 (3,502) (205)
(Loss)/income before income taxes (35,222) 121 51,039
Income tax expense 433 10,546 14,406
Net (loss)/income $ (35,655) $ (10,425) $ 36,633
(Loss)/earnings per share—basic $ (0.25) $ (0.08) $ 0.23
(Loss)/earnings per share—diluted $ (0.25) $ (0.08) $ 0.23
Weighted-average common shares—basic 148,682 151,823 146,645
Weighted-average common shares—diluted 148,682 [1] 151,823 [1] 158,415
Cash dividends declared per common share $ 0.12 $ 0.12 $ 0.12
Advisory Fees [Member]      
Operating Revenues:      
Total revenues $ 250,182 $ 265,652 $ 271,104
Other Income [Member]      
Operating Revenues:      
Total revenues $ 3,517 $ 2,751 $ 3,012
[1] Excludes 15,121,702 and 15,001,511 participating securities for the years ended December 31, 2020 and 2019, respectively, as the Company reported a net loss for those periods. Also excludes 6,087 and 152,085 potentially dilutive common stock equivalents for the years ended December 31, 2020 and 2019, respectively, as the Company reported a net loss for those periods.